News | June 18, 2026
Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
CEO Stéphane Bancel framed the changes as essential to scaling the business
CEO Stéphane Bancel framed the changes as essential to scaling the business
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
Leading experts from AIIMS Kalyani, Syngene, Veeda Lifesciences, Lambda Therapeutic, DNDi, JSS Medical, KIHT, InoRx, ISCR and SIRO Clintech to discuss India’s readiness as preferred clinical research destination
The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
The decision was driven by results from the Phase III CAPItello-281 trial,
Approval is based on results from the phase 3 OASIS 4 clinical trial
Partnership will provide funding, incubation, mentorship, and industry exposure for ventures in healthcare, pharmaceuticals, biotechnology, medical technology, and agriculture
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
The milestone, announced from Wilmington, Delaware, is powered through additional Renewable Energy Certificates (RECs) and backed by US-sourced renewable generation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
